EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Kamila J Bienkowska, Stephany Gallardo, Nur S Zainal, Leena Arora, Matthew Ellis, Maria-Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier und 2 weitere

Molecular Oncology · 27.05.2026

DOI: 10.1002/1878-0261.70263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 27.05.2026. Verfasst von Kamila J Bienkowska und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Cancer Sciences, University of Southampton, Southampton, UK. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rosetrees Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular plasticity is central to non‐small cell lung cancer ( NSCLC ) disease progression and linked to aberrant regulation of developmental programmes. Here, we investigated the contribution of two developmental programmes, alveogenesis ( ALV ) and branching morphogenesis ( BM ), to NSCLC disease progression. ALV and BM inversely correlated across multiple transcriptome datasets. In squamous carcinomas ( LUSC ), ALV suppression and BM activation were consistently observed relative to controls, but these features were not prognostic. In contrast, adenocarcinomas ( LUAD ) displayed heterogeneous BM activation, associated with poor overall survival in several observational cohorts ( n = 5) and resistance to tyrosine kinase inhibitors or immune checkpoint blockade. Exome sequencing linked TP53 pathway mutations to BM activation in LUAD , which was validated in conditional Trp53 knock‐out mouse models. Single‐cell RNA ‐sequencing combined with multiplexed immunohistochemistry showed LUAD BM activation reflected increased morphological grade with tumour cells transdifferentiating to a basal‐like cell state. Finally, 3D organotypic cultures identified type‐I interferon signalling as a driver of BM activation in TP53 ‐mutant LUAD . Collectively, our findings reveal a novel TP53 ‐interferon axis that promotes transcriptomic plasticity in LUAD , with important implications for biomarker and therapeutic target discovery.

Schlagwörter

Stichwörter der Autor:innen

TP53Type‐I interferoncellular plasticitydevelopmental programslung adenocarcinoma (LUAD)therapy resistance

Autor:innen und Institutionen

  • School of Cancer Sciences, University of Southampton, Southampton, UK.
  • Department of Histopathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Institute of Systems, Molecular and Integrative Biology (ISMIB) and Liverpool Experimental Cancer Medicines Centre, University of Liverpool, Liverpool, UK.
  • Department of Thoracic surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Cancer Research UK and NIHR Southampton Experimental Cancer Medicine Centre, Southampton, UK.

ORCID-Profile: Christopher J Hanley

Förderung

  • Rosetrees Trust

Zitieren

APA

Bienkowska, K. J., Gallardo, S., Zainal, N. S., Arora, L., Ellis, M., Lopez, M. A., Austine, J., Pittla, S., Chee, S. J., Alzetani, A., Shaw, E. C., Ottensmeier, C. H., Thomas, G. J., & Hanley, C. J. (2026). Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma. Molecular Oncology. https://doi.org/10.1002/1878-0261.70263

Vancouver

Bienkowska KJ, Gallardo S, Zainal NS, Arora L, Ellis M, Lopez MA, et al. Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma. Molecular Oncology. 2026. doi:10.1002/1878-0261.70263

BibTeX
@article{Bienkowska2026,
  author = {Bienkowska, Kamila J and Gallardo, Stephany and Zainal, Nur S and Arora, Leena and Ellis, Matthew and Lopez, Maria-Antoinette and Austine, Judith and Pittla, Sai and Chee, Serena J and Alzetani, Aiman and Shaw, Emily C and Ottensmeier, Christian H and Thomas, Gareth J and Hanley, Christopher J},
  title = {Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma},
  journal = {Molecular Oncology},
  year = {2026},
  doi = {10.1002/1878-0261.70263}
}
Kostenlos starten →